NCT00854113View on ClinicalTrials.gov

Study to Determine the Safety, Tolerability, and Pharmacokinetic (PK) Profile of EGT0001474 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
Safety and Tolerability of EGT0001474 in Healthy Volunteers
Interventions
DRUG

EGT0001474

Oral ascending doses given daily as capsules for up to 14 days

DRUG

Placebo

Placebo to match EGT0001474

Trial Locations (1)

53704

Covance Clinical Research Unit, Madison

Sponsors

Lead Sponsor

Theracos
All Listed Sponsors
lead

Theracos

INDUSTRY

NCT00854113 - Study to Determine the Safety, Tolerability, and Pharmacokinetic (PK) Profile of EGT0001474 in Healthy Volunteers | Biotech Hunter | Biotech Hunter